Page last updated: 2024-09-03

n-methylisoindigotin and Diabetes Mellitus, Type 2

n-methylisoindigotin has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, J; Liu, JJ; Ma, N; Mu, YL; Shentu, LM; Sun, Y; Wang, LY; Wang, Y; Zhang, GM1

Other Studies

1 other study(ies) available for n-methylisoindigotin and Diabetes Mellitus, Type 2

ArticleYear
Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats.
    Current medical science, 2020, Volume: 40, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lipid Metabolism; Male; Myocytes, Cardiac; NF-kappa B; Pyrrolidines; Rats; Streptozocin; Thiocarbamates; Wnt Signaling Pathway

2020